Royal Jubilee Hospital is a 500-bed general hospital in Victoria, British Columbia, Canada located about 3 km east of the city centre, in the Jubilee neighbourhood.

There are 500 beds in Royal Jubilee Hospital.

During the past decade, Royal Jubilee Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 12 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Jubilee Hospital" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored, "Daren K. Heyland" with 2 trials sponsored and "Ottawa Heart Institute Research Corporation" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Jubilee Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 8 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Abbott Medical Devices" with 2 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Royal Jubilee Hospital" are "Coronary Artery Disease" (3 trials), "Heart Failure" (3 trials), "Cerebrovascular Accident" (2 trials), "Critical Illness" (2 trials) and "Paroxysmal Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Royal Jubilee Hospital" in a lesser frequency.

Most popular intervention types in "Royal Jubilee Hospital" are "Drug" (18 trials), "Device" (8 trials), "Other" (8 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "Accelerated RRT initiation" (1 trials), "Additional ablation until elimination of dormant conduction" (1 trials) and "Antiarrythmic Drug Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Jubilee Hospital" are 35 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Jubilee Hospital". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Royal Jubilee Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Jubilee Hospital, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 11 trials that are defined as “Not Applicable".